Prof. Dr. Mark Pletscher

Profile

Prof. Dr. Mark Pletscher Leiter Gesundheitsökonomie und -politik

  • Address Berner Fachhochschule
    Health Professions
    Institut für G-ökonomie und G-politik
    Stadtbachstrasse 64
    3012 Bern

Teaching

CV

  • 2015 - 2019 Health economist, F. Hoffmann-La Roche Ltd
  • 2009 - 2015 Research associate / lecturer, Winterthur Institute of Health Economics
  • 2008 - 2009 Scientific assistant, Military Academy at ETH Zurich
  • PhD in health economics, University of Neuchâtel
  • International doctoral courses in health economics and policy, Swiss School of Public Health, SSPH+
  • Master of Arts in Economics, University of Zurich

Publications

  • Wieser, S., M. Riguzzi, M. Pletscher, C.A. Huber, H. Telser, M. Schwenkglenks (2018): "How much does the treatment of each major disease cost? A decomposition of Swiss National Health Accounts". The European Journal of Health Economics, online first.

  • Girardin, F., A. Poncet, A. Perrier, M. Pletscher, F. Samer, J.A. Liebermann, J. Villard (2018): "Cost-effectiveness of HLA-DQB1/HLA-B pharmacogeneticguided treatment and blood monitoring in US patients taking clozapine". Pharmacogenomics, online first.

  • Pletscher, M. (2017): "The effects of organized screening programs on the demand for mammography". The European Journal of Health Economics, 18(5), 649-665.

  • Gencer, B., N. Rodondi, R. Auer, D. Nanchen, L. Räber, R. Klingenberg, M. Pletscher, P. Jüni, S. Windecker, C.M. Matter, T.F. Lüscher, F. Mach, T.V. Perneger, F.R. Girardin (2016): "Health utility indexes in patients with acute coronary syndromes". Open Heart, 3(1).

  • Pletscher, M., S. Walker, K. Moschetti, C. Pinget, J.-B. Wasserfallen, J.P. Greenwood, J. Schwitter, F. Girardin (2016): "Cost-effectiveness of functional cardiac imaging in the diagnostic work-up of coronary heart disease". The European Heart Journal - Quality of Care and Clinical Outcomes, in press, doi:10.1093/ehjqcco/qcw008.

  • Pletscher, M. (2015): "Marginal revenue and length of stay in inpatient psychiatry". The European Journal of Health Economics, 17(7), 897-910.

  • Pletscher, M., R. Mattli, O. Reich, A. von Wyl, S. Wieser (2014): "The societal costs of schizophrenia in Switzerland". The Journal of Mental Health Policy and Economics, 18(2), 93-103.

  • Pletscher, M., R. Plessow, K. Eichler, S. Wieser (2013): "Cost-effectiveness of dabigatran for stroke prevention in atrial fibrillation in Switzerland". Swiss Medical Weekly, 143, w13732.

  • Wieser, S., I. Rüthemann, S. De Boni, K. Eichler, M. Pletscher, D. Radovanovic, T. Ulle, H. Auerbach (2012): "Cost of acute coronary syndrome in Switzerland in 2008". Swiss Medical Weekly, 142, w13655.

  • Pletscher, M. (2017): "The effects of organized mammography screening on breast cancer mortality in Switzerland - Early evidence from a natural experiment". Working paper, September 2017.

  • Wieser, S., M. Riguzzi, M. Pletscher, M. Dettling (2014): "Development of a prospective payment system for inpatient psychiatry in Switzerland". Report on behalf of the Swiss Association of Hospitals, H+.

  • Wieser, S., Y. Tomonaga, M. Riguzzi, B. Fischer, H. Telser, M. Pletscher, K. Eichler, M. Trost, M. Schwenkglenks (2014): "The costs of non-communicable diseases in Switzerland". Report on behalf of the Swiss Federal Office of Public Health.

  • Pletscher, M.(2012): "Health Literacy and Outpatient Service Use in Switzerland". The Geneva Association Health and Ageing Newsletter, 27.

  • Pletscher, M., S. Wieser (2012): "The use of methylphenidate in children and adolescents: Insurance claims data shows increase between 2005 and 2008". BAG Bulletin, 26 443-446.

  • Wieser, S., R. Schleiniger, M. Pletscher, R. Plessow, U. Brügger (2011): "Unified health insurance funds: Economic assessment of the advantages and drawbacks". Report on behalf of the Conference of Cantonal Health Directors, eastern Switzerland.

  • Hess, S., M. Pletscher, K. Eichler, U. Brügger (2010): "Update of the economic literature on a healthy body weight". Report on behalf of Health Promotion Switzerland.

  • Wieser, Simon, L. Kauer, S. Schmidhauser, M. Pletscher, U. Brügger, C. Jeanrenaud, S. Flügister-Dousse, D. Kohler, J. Marti (2009): "Economic evaluation on health promotion and prevention in Switzerland". Synthesis report on behalf of the Swiss Federal Office of Public Health.

  • Kauer, Lukas, M. Pletscher, S. Wieser, U. Brügger (2009): "Assessment of the availability and quality of Swiss data required to conduct a full CBA in the field of obesity prevention - Part II of the project ’Exploratory study on obesity: Economic evaluation on health promotion and prevention’. Report on behalf of the Swiss Federal Office of Public Health.

  • Szvircsev, T, A. Wenger, S. Würmli, M. Pletscher and U. Wenger (2009): "Security 2009: Trends in the public perception of foreign, security and defence policy". Swiss Military Academy at ETH Zurich.

  • Pletscher, M, S. Gsteiger (2019): "Discrete time restricted cubic spline models for network meta-analysis of time-to-event outcomes" Poster presented at ISPOR Annual European Congress: November 2019, Copenhagen.

  • Loughran, T., A. Reyes, M. Pletscher, T. Krivasi, A.J. Hatswell (2017): "Mapping from SF-36 Trial Data To EQ-5D Utilities in Advanced Basal Cell Carcinoma". Poster presented at ISPOR 20th Annual European Congress: November 2017, Glasgow.

  • Pletscher, M., M. Carreras, A. Wong, R. Doshi (2016): "Don’t Put Off Until Tomorrow What You Can Do Today: Cost-Effectiveness of Trastuzumab Plus Paclitaxel Combination Therapy and Sequential use of Paclitaxel and Trastuzumab in the Treatment of Metastatic Breast Cancer in Singapore". Poster presented at ISPOR 7th Asia-Pacific Conference: September 2016, Singapore.

  • Pletscher, M., R. Mattli, K. Eichler, S. Wieser (2013): "Inpatient hospital costs of febrile neutropenia as a consequence of chemotherapy for breast cancer and Non-Hodgkin lymphoma in Switzerland". Poster presented at ISPOR 16th Annual European Congress: November 2013, Dublin.

  • Wieser, S., P. Brühlmann, D. Kyburz, R. Plessow, M. Pletscher, U. Brügger (2010): "Cost-effectiveness of Tocilizumab in Switzerland: A microsimulation approach". Poster presented at SGR Annual Congress, 9. September 2010, Fribourg.

Memberships

  • 2012 - present: The Nursing Science Foundation Switzerland, Basel - Member of the scientific committee

  • 2009 - 2017: Management, Information and Communication Training staff, Swiss Military - Communication skills trainer, module developer